IMS forecasts worldwide pharmaceutical sales to increase 4.5%–5.5%, in 2009, the same as 2008’s growth, to more than $820 billion. Oncology products will drive growth, with sales expected to increase 15%–16%. Also driving sales growth will be HIV therapies, which are forecasted to grow 13%–14%, and biologics, which are expected to grow 11%–12%. Sales of […]

Research published in the Journal of the American Medical Association (JAMA) this month indicates that regulatory actions related to safety concerns have been issued for 23.6% of the biological medicinal products approved for sale in the US and EU between January 1995 and June 2008. Of the 174 biologicals approved for sale in the regions […]

The European Commission’s annual EU Industrial R&D Investment Scoreboard shows that total R&D spending by 2,000 companies increased by 9% to €379.3 billion ($553.8 billion) in 2007. Half of the companies in the Scoreboard are EU companies, and the other half are non-EU companies. This method allows the Scoreboard to show yearly R&D spending by […]

A cursory analysis of calendar-year third- quarter results of eight major publicly held instrument and laboratory product companies (Applied Biosystems, Bruker, Dionex, Illumina, Invitrogen, Thermo Fisher Scientific, Waters and Varian) show that the global economic crisis did not significantly affect third-quarter sales of analytical instruments and related products. In their quarterly conference calls, most companies […]

For most people, the word electrochemistry may conjure up the image of the humble pH meter, but this field of laboratory analysis is actually very multi-faceted, with numerous distinct techniques. Fundamentally, these techniques all measure aspects of chemical reactions that involve the transfer of electrons in solution. This transfer of electrons can be measured as […]

On October 14, the EU formerly launched the Fuel Cells and Hydrogen Joint Technology Initiative (JTI). The JTI consists of more than 60 companies, more than 60 universities and research institutes, and the European Commission. With funding of close to €1 billion ($1.4 billion) over six years, the JTI plans to accelerate the development, commercialization […]

The HPLC aftermarket accounts for more than 40% of the total HPLC market worldwide and is an important component of the market’s total growth. The majority of the HPLC aftermarket consists of HPLC columns. Although Waters and Agilent may dominate the HPLC system market, it is another company that leads the HPLC column market. Founded […]

Company Announcements Geneva Bioinformatics named GE Healthcare Life Sciences as its Latin American distributor. Abbott has made an additional $20 million investment in Ibis Biosciences (see IBO 2/15/08), bringing its equity holding to 18.6%. Thermo Fisher Scientific integrated its MS instrumentation with Genedata’s Genedata Expressionist software for metabolomics applications. The Thermo Fisher Scientific Biomarker Research […]

Company Announcements Invitrogen and the International Regulome Consortium will codevelop tools for stem cell research. Promega will develop fluorescent ligands for its HaloTag fusion proteins to be used with Leica’s TCS stimulated emission depletion super-resolution microscope. Under an exclusive license with the University of Georgia Research Foundation, ArunA Biomedical will commercialize human mesenchymal cells derived […]